Single hyaluronan J-code could lower your drug pay next year

Why This Topic Matters

A single billing code can change how hyaluronan products are reimbursed across brands, affecting practice revenue, drug selection, and payer behavior. Coders, billing staff, and providers need to understand the change to avoid claim issues and anticipate payment differences.

Article Sections

1. New HCPCS drug code and reporting change

   Introduces the upcoming HCPCS update for hyaluronan products and explains the broad shift in how the injections will be reported.

2. Reimbursement concerns for different brands

   Describes concerns from orthopedic practices about how a single payment rate may affect products with different acquisition costs.

3. Medicare drug fee schedule and pricing updates

   Summarizes how Medicare updates drug fees and notes the timing and general basis for the new payment amount.

4. Manufacturer reactions and coding implications

   Covers responses from manufacturers and the broader concern about how the coding decision may affect claims processing and reimbursement.

5. Clinical speak and resources

   Provides a brief clinical overview of hyaluronic acid and points readers to CMS resources related to HCPCS and drug pricing.